MedPath

Clinical stusy of induction S-1+Oxaliplatin+/-Cetuximab chemotherapy followed by short-course chemoradiotherapy in locally advanced ugly rectal cancer

Phase 2
Recruiting
Conditions
locally advanced rectal cancer
Registration Number
JPRN-UMIN000017720
Lead Sponsor
Meiwa Hospital department of surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

inflammatory bowel disease cardiac disease medical conditions that would not permit the patient to complete the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pathologival complete response rate
Secondary Outcome Measures
NameTimeMethod
Adverse event Compliance to induction chemotherapy R0 resection rate Down-staging rate(T,N stage) Tumor regression grade LFS; local recurrence free survival RFS; Recurrence free survival OS; Overall survival
© Copyright 2025. All Rights Reserved by MedPath